Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 54 of 59, showing 10 Applications out of 584 total, starting on record 531, ending on 540

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

531.

ECCT/13/05/01  
    Use of the Shang Ring device in all four childhood age groups in the African population   
Principal Investigator(s)
1. Quentin David Awori
Site(s) in Kenya
Homa Bay District Hospital
 
18-04-2013 View

532.

ECCT/13/04/04   Enteric Study
    A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens with Loperamide for Treatment of Ambulatory Watery Travelers’ Diarrhea, and Azithromycin with and without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea   
Principal Investigator(s)
1. CPT Brook A. Danboise
Site(s) in Kenya
British Army Training Unit, Kenya (BATUK)
 
26-03-2013 View

533.

ECCT/13/04/09   Short-course RPT/INH for latent TB in HIV-infected individuals
        Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah C. Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
26-03-2013 View

534.

ECCT/13/04/03   HIV-Malaria Study_A5297
        An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of    Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3 .   
Principal Investigator(s)
1. Josphat K. Kosgei
Site(s) in Kenya
1. Kemri Walter Reed Project-Kericho (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
26-03-2013 View

535.

ECCT/13/04/02  
    XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study   
Principal Investigator(s)
1. Dr Charles Muthui Kariuki
Site(s) in Kenya
Nairobi Cardiovascular Clinic
 
06-03-2013 View

536.

ECCT/11/12/04   PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial
    A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults   
Principal Investigator(s)
1. FREDRICK KIPYEGO SAWE
Site(s) in Kenya
KEMRI/Walter Reed Project-Kericho
 
15-02-2013 View

537.

ECCT/13/03/01  
    Assessing the acceptability of a progesterone vaginal ring (PVR) as a new contraceptive option in sub-Saharan Africa   
Principal Investigator(s)
1. Obare Francis
Site(s) in Kenya
1. Ngoliba Health Centre (Kiambu county)
2. Kirwara Sub-district Hospital (Kiambu county)
3. Igegania Sub-district Hospital (Kiambu county)
4. Makadara Health Centre (Nairobi City county)
5. Thika Level 5 (Kiambu county)
6. Ruiru Sub-district Hospital (Kiambu county)
 
13-02-2013 View

538.

ECCT/10/09/05   A5225/ HiFLAC
    A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis       A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)   
Principal Investigator(s)
1. Deborah Chepngeno langat
Site(s) in Kenya
1.
 
08-02-2013 View

539.

ECCT/13/10/03  
    The Impact of Supplementation with Iron and Vitamin B12 Singly and In Combination on Nutritional Status and Morbidity Among Primary School Children.   
Principal Investigator(s)
1. Priscilla Monyangi Dr. Nyakundi
Site(s) in Kenya
Kilifi County, Ganze District.
 
02-02-2013 View

540.

ECCT/12/12/01  
        A pilot study to optimise controlled human malaria infections in humans with varying degrees of prior exposure to malaria using P. falciparum sporozoites administered by needle and syringe   
Principal Investigator(s)
1. Bernhards Ogutu
2. Kevin Marsh
Site(s) in Kenya
Kenya Medical Research Institute, Centre for Clinical Research, Nairobi
 
18-01-2013 View